TOPOTECAN Accord conc perf 4 mg 5 pce
7680668100033
CH-66810
L01CE01
07.16.1.
Active substances:
1 / 3
google
Details
- Product number
- 6681002
- CPT
- -
- Packaging group
- 5
- Unit
- Durchstechflasche(n)
- Composition
- topotecanum 4 mg ut topotecani hydrochloridum, acidum tartaricum, natrii hydroxidum ad pH, acidum hydrochloridum ad pH, aqua ad iniectabile q.s. ad solutionem pro 4 ml.
Articles (1)
Topotecan Accord 4 mg, Konzentrat zur Herstellung einer Infusionslösung
Konzentrat
5
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
topotecanum
|
4.0 MG | Substance | Wirkstoff (Principe actif) |
|
topotecani hydrochloridum
|
- | Substance | WIZUS |
|
acidum tartaricum
|
- | Substance | HNIDK |
|
natrii hydroxidum
|
- | Substance | HNIDK |
|
acidum hydrochloridum
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1331.70
Specialties list
Yes
Generic
Yes
Reimbursement limitation
SL addition date:
01/07/2019
Authorization holder
Accord Healthcare AG
4103 Bottmingen
Authorization information
- Swissmedic authorization number
- 66810
- Drug name
- Topotecan Accord, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L01CE01
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 15/03/2019
- Authorization expiration date
- 31/12/9999
- IT number
- 07.16.1.
- Domain
- Human medicine
Packaging details
- Description (FR)
- TOPOTECAN Accord conc perf 4 mg 5 pce
- Description (DE)
- TOPOTECAN Accord Konz Inf 4 mg 5 Stk
- Market launch
- 15/03/2019
- Narcotic (BTM)
- No